Reply To: MA and Signals

Home Forums Pharmacovigilance Forum MA and Signals Reply To: MA and Signals

#39857

Dear Member

Please note that the response to your query represents the views and suggestions of the PIPA Committee Members and are intended as guidance. Please also refer to guidelines and your own company procedures.

As per GVP Module IX Signal Management, The marketing authorisation holder in the EU should continuously monitor the safety of their medicinal products and inform the authorities of any new information that might have an impact on the marketing authorisation.

We hope this helps.

Kind regards,

PIPA